All USA USA Territories: American Samoa (USA); Guam (USA); Puerto Rico (USA); Virgin Islands (USA); Northern Mariana Islands (USA); USA Compact Free Associations:The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA) International, Israel and Canada.
Grants to USA, Canada, and International investigators affiliated with qualified institutions for autism research involving humans and animals. Funding is intended to support multi-disciplinary teams of investigators experienced with both animal and human research to engage in coordinated studies. The purpose of the grant is to advance the understanding of ASD-relevant behaviors and their underlying neurobiological mechanisms, with the potential for developing novel biomarkers or interventions.
Grants awarded through the Cross-Species Studies of ASD request for applications (RFA) are intended to support multi-disciplinary teams of PIs with expertise in both human and animal research to perform coordinated cross-species studies to advance the understanding of ASD-relevant behaviors and their underlying neurobiological mechanisms, with the potential for developing novel biomarkers or interventions.
SFARI has long supported studies in humans (including in the Human Cognitive and Behavioral Science RFA) and in non-human animals, with both focused on improving our understanding of ASD. However, as discussed at a workshop in 2018 and in many venues since then, improving coordination of the research performed in humans and in model organisms would greatly benefit ASD research (as well as other areas of psychiatric and neuroscience research). Studies in animals seeking to elucidate the neural mechanisms underlying behavior are more likely to be relevant to the human condition if the phenotypes under study in animals are known to be conserved in humans and germane to ASD. Conversely, studies of neural mechanisms and behavior in humans are likely to be enriched by incorporation of novel quantitative methods and analytic tools used in studies of non-human animals. Grants awarded through the Cross-Species Studies of ASD request for applications (RFA) are intended to support multi-disciplinary teams of PIs with expertise in both human and animal research to perform coordinated cross-species studies to advance the understanding of ASD-relevant behaviors and their underlying neurobiological mechanisms, with the potential for developing novel biomarkers or interventions.
Others (see text field entitled "Additional Eligibility Criteria" for clarification)
Additional Eligibility Criteria
Eligibility
All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility.
Principal investigators (PIs) who do not have substantial expertise with ASD participants should include a close collaborator with such expertise on their grant application (e.g., multi-PI application). For animal researchers interested in applying to this RFA who do not have an existing collaboration with someone who studies humans with ASD, please reach out to SFARI staff via email; they may be able to help identify appropriate and interested potential collaborators.
SFARI recognizes the importance of diverse viewpoints for scientific advancement. As such, SFARI encourages the inclusion of researchers who span career stages and groups historically underrepresented in science.
Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories and units of state and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.
Pre-Proposal Conference
To answer questions about this RFA, SFARI will hold an informational Zoom meeting on January 23, 2023, at 12:00 p.m. EST. This webinar will also include breakout sessions in which interested researchers may be able to identify or connect with potential collaborators. More information and registration for the webinar will be available soon. See the URL for Full Text, below.
Pre-Application Information
Timeline:
- Application Available: April 5, 2023
- Application Deadline: June 15, 2023
- Award Notification: November 20, 2023
Applications must be submitted via the Simons Award Manager (SAM), which will open for applications on April 5, 2023. Applications are due by June 15, 2023. Please click on the Funding Opportunities icon and navigate to the Simons Foundation Autism Research Initiative — Cross-Species Studies RFA call. Click the Create Application button to begin. Applications should be started and submitted under the applicant’s own account in SAM.
Applicants may request a maximum of $400,000, inclusive of 20 percent indirect costs, for each year of funding.
Term of Contract
Period of two (2) to three (3) years
Awards may begin as early as January 2024, but PIs are encouraged to select a project start date that best accommodates the needs of their project. Funds are expected to be expended as requested during each annual budget period. Projects must begin on the first of the month.
We use cookies to enhance your browsing experience on GrantWatch.com. By continuing to use our site, you consent to the use of cookies. Learn more by exploring our comprehensive Cookie Policy
